Elevated expression of enhancer of zeste homolog 2 (EZH2), a histone H3K27 methyltransferase, was observed in gliomas harboring telomerase reverse transcriptase (TERT) promoter mutations. Given the known involvement of TERT and EZH2 in glioma progression, the correlation between the two and subsequently its involvement in metabolic programming was investigated. Inhibition of human telomerase reverse transcriptase either pharmacologically or through genetic manipulation not only decreased EZH2 expression, but also (i) abrogated FASN levels, (ii) decreased de novo fatty acid accumulation, and (iii) increased ataxia-telangiectasia-mutated (ATM) phosphorylation levels. Conversely, diminished TERT and FASN levels upon siRNA-mediated EZH2 knockdown indicated a positive correlation between TERT and EZH2. Interestingly, ATM kinase inhibitor rescued TERT inhibition-mediated decrease in FASN and EZH2 levels. Importantly, TERT promoter mutant tumors exhibited greater microsatellite instability, heightened FASN levels and lipid accumulation. Coherent with in vitro findings, pharmacological inhibition of TERT by costunolide decreased lipid accumulation and elevated ATM expression in heterotypic xenograft glioma mouse model. By bringing TERT-EZH2 network at the forefront as driver of dysregulated metabolism, our findings highlight the noncanonical but distinct role of TERT in metabolic reprogramming and DNA damage responses in glioblastoma.
Human telomerase reverse transcriptase (hTERT), the catalytic subunit of the telomerase, is required for telomere maintenance and cancer cell immortalization. TERT promoter mutation creates a putative binding site for E26 transformation-specific/ternary complex factors (Ets/TCF) transcription factors that promotes enhanced telomerase expression and activity (Huang et al. 2013) . The prevalence of TERT promoter mutations associated with enhanced expression of telomerase is remarkably high in adult glioblastomas (GBMs) (Killela et al. 2013) . We have recently demonstrated that inhibition of hTERT not only induces glioma cell apoptosis, but also abrogates pentose phosphate pathway (PPP) (Ahmad et al. 2016) . The PPP provides NADPH required for fatty acid synthesis (Kather et al. 1972) , as well as substrates for RNA synthesis and co-factors for de novo lipogenesis (Summermatter et al. 2010) . Fatty acid synthase (FASN), a key metabolic enzyme involved in de novo lipogenesis, is over-expressed in gliomas (Grube et al. 2014) . The importance of FASN in contributing to tumor progression has been demonstrated by the ability of pharmacological inhibitors of FASN to trigger tumor cell apoptosis (Flavin et al. 2010) . Although dysregulated metabolism, including aberrant lipid metabolism, is recognized as a hallmark of various cancers, little is known about the involvement of TERT in the regulation of lipid metabolism in GBM. Given the known link between PPP and lipogenesis, and our recent findings that hTERT regulates PPP in glioma, we investigated the involvement of TERT in fatty acid metabolism.
The methyltransferase polycomb group protein enhancer of zeste homolog 2 (EZH2), the catalytic factor of the polycomb repressive complex 2 (PCR2), regulates gene expression by methylating lysine 27 on histone H3 (H3K27me3) (Sparmann and van Lohuizen 2006) . H3K27me3 is necessary for polycomb repressive complex 2-mediated gene repression (Cao et al. 2002) . High expression of EZH2 has been linked to progression of several malignancies (Varambally et al. 2002; Kleer et al. 2003) . EZH2 is highly expressed in GBM as compared to low-grade gliomas (Orzan et al. 2011) , with EZH2-STAT3 (signal transducer and activator of transcription 3) interaction promoting tumorigenicity of glioma stem cells (Kim et al. 2013) . To investigate the H3K27me3 targets and their relationship with gene expression in astrocytic tumors, we have recently used genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) analysis to evaluate the status of EZH2-mediated H3K27me3 target genes in adult high-grade GBMs with respect to normal brain and lowgrade gliomas. This high-resolution genome-wide mapping of H3K27me3 modification has shown higher enrichment of H3K27me3 targets in glioma stem cells of GBMs as compared to diffuse astrocytomas . Importantly, the chromatin states of wild-type and mutant TERT promoters in several cancer cell lines differ, with mutant and wild-type TERT promoter exhibiting H3K4me2/3 and H3K27me3 mark of active and silenced chromatin, respectively (Stern et al. 2015) . H3K27me3 epigenetic mark on the promoter of lipogenic genes affects their expression (Podrini et al. 2015) , and FASN-mediated de novo lipid biosynthesis promotes glioma tumor growth and invasion (Yasumoto et al. 2016) . Interestingly, FASN inhibition enhances DNA damage response (Zeng et al. 2008) . Elevated EZH2 expression in breast tumor initiating cells increases genomic abnormality (Chang et al. 2011) , and EZH2 is an (phospho) ataxiatelangiectasia-mutated (ATM) target (Li et al. 2013) . Moreover, short telomeres elicit genome-wide DNA hypomethylation and altered H3K27me3 levels (Pucci et al. 2013) .
Transcriptional regulation is dependent on a vast network of epigenetic modifications, and H3K27me3 mark catalyzed and maintained by EZH2 affects local pattern of enrichment and consequently gene expression. Although the links between EZH2, H3K27me3 repressive mark and gene expression have been extensively explored, the involvement of EZH2 in regulation of lipid metabolism in the context of glioma has not been studied. As remodeling of the epigenetic landscape by EZH2 affects gene expression, and since targeting of mutation driven TERT reactivation in glioma has immense therapeutic implications (Li et al. 2015) , we investigated the correlation between TERT and EZH2, and subsequently the mechanistic links between genes involved in lipid metabolism and DNA repair pathways.
Materials and methods
Cell culture and treatment Human glioma cell lines A172 (ATCC Cat # CRL-1620; RRID: CVCL_0131) and U87MG (ATCC Cat # HTB-14; RRID: CVCL_0022) obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS) (Cat # 16140071; Gibco, Rockville, MD, USA) and penicillin (100 U/mL)/streptomycin (100 lg/mL) (Cat # 15140122; Gibco). The cells were passaged for fewer than 6 months after resuscitation. On attaining semi-confluence, cells were switched to serum-free media for 4 h and treated with costunolide (30 lM) [(Cat # 2483; Tocris Bioscience, Bristol, UK) for 24 h. Similarly, cells were treated with betulin (100 lM) (Cat # 92648; Sigma-Aldrich, Darmstadt, Germany)]. Cells were pre-treated with ATM kinase inhibitor KU60019 (2.5 mM) (Cat # 2483; Tocris Bioscience) for 2 h in serum-free media followed by treatment with costunolide in the presence or absence of KU60019 for 24 h. Dimethyl sulfoxide (DMSO) (Cat # D8418; Sigma-Aldrich)-treated cells served as controls.
Transfection
Transfections with duplex hTERT (75 nmol/L) (SMARTpool: ON-TARGETplus TERT siRNA L-003547-00-0005) and EZH2 (50 nmol/L) (SMARTpool: ON-TARGETplus EZH2 siRNA L-004218-00-0005) specific siRNAs, and non-specific (NS) siRNAs (siGENOME Non-Targeting siRNA #3 D-001210-03-20 20) or with over-expression constructs for dominant negative-hTERT (DN-hTERT) (Plasmid #1775; Addgene, Cambridge, MA, USA), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a) (Plasmid #10974; Addgene) or corresponding empty vectors (E.Vectors) were carried out using Lipofectamine RNAi Max reagent (Cat # 13778150) or Lipofectamine 2000 reagent (Cat # 11668027) (Invitrogen, Waltham, MA, USA) in Opti-MEM (Cat # 51985034; Gibco) as described previously (Ghosh et al. 2013) . Cells transfected with NS or specific siRNA, and expression vectors or empty vectors were either harvested 24 h post-transfection or treated with costunolide for additional 24 h. Control non-targeting siRNA as well as siRNAs targeting hTERT and EZH2 were obtained from Dharmacon (Lafayette, CO, USA).
Generation of heterotypic glioma xenografts
Heterotypic xenografts were generated as described previously. Briefly, U87MG cells were injected subcutaneously in the flank of 25 anesthetized athymic nude mice. When measurable tumors, 5-6 mm in diameter, were formed after 15 days of injection, animals were arbitrarily divided into two groups of eight each (including both males and females) and were treated with either vehicle or costunolide intraperitoneally (5 mg/kg body weight) on alternate days for 20 days, following which they were killed and xenograft tumor tissues were processed for subsequent experiments (Ahmad et al. 2016) . The mice which did not present with tumors of 5-6 mm diameter (9 in number) after 15 days of injection were excluded from the study. No sample size calculation was performed. The animals were procured from National Institute of Nutrition, Hyderabad, India (RRID not available). All the experimental procedures were in accordance with the guidelines of the Institutional Animal Ethics Committee of NBRC (Approval No. NBRC/ IAEC/2013/86).
Determination of cell viability
Viability of cells treated with different concentrations of betulin was assessed using MTS assay (Cat # PR-G3580; Promega, Madison, WI, USA), as described previously (Dixit et al. 2009 ). Values were expressed as percentage change compared to controls.
Western blot analysis
Western blot analysis was performed on protein lysates isolated from control and transfected/treated cells and tumor tissues as described previously (Tewari et al. 2012 ) using antibodies against EZH2 (Cat # ab3748; Abcam, Cambridge, UK; RRID:AB_304045), H3K27me3 (Cat # ab6002; Abcam; RRID:AB_305237), pATM (phospho S1981) (Cat # ab2888; Abcam), ATM (Cat # ab78; Abcam; RRID:AB_306089), FASN (Cat # 3180S; Cell Signaling, Danvers, MA, USA; RRID:AB_2100796), sterol regulatory element-binding protein-1 (SREBP-1) (Cat # NB600-582; Novus Biologicals, Littleton, CO, USA; RRID:AB_10001575), hTERT (Cat # NB120-32020; Novus Biologicals; RRID:AB_805603), PGC-1a (Cat # NBP1-04676; Novus Biologicals; RRID: AB_1522118), MutS protein homolog 2 (MSH2) (Cat # sc-494; Santa Cruz Biotechnology, Santa Cruz, CA, USA; RRID: AB_631975), c23 (Cat # sc-55486; Santa Cruz Biotechnology; RRID:AB_670272) and b-Actin (Cat # A3854; Sigma-Aldrich; RRID:AB_262011). Horseradish peroxidase-labeled secondary antibodies -anti-rabbit IgG (Cat # PI-1000; RRID:AB_2336198) and anti-mouse IgG (Cat # PI-2000; RRID:AB_2336177) were purchased from Vector Laboratories, Inc. (Burlingame, CA, USA). Images were captured using Chemigenius Bioimaging System (Syngene, Bangalore, India) after the addition of chemiluminescent horseradish peroxidase substrate (Cat # WBULS0500; Merck Millipore, Billerica, MA, USA).
Oil red staining
Oil red (Cat # sc-203749; Santa Cruz Biotechnology) staining was performed on frozen sections of control and costunolide-treated xenograft tumors, and on histologically confirmed TERT-mutant and wild-type GBM tissues as described previously (Mehlem et al. 2013) . Images were captured under Leica DMRXA2 bright-field microscope (Wetzlar, Germany).
Immunohistochemistry
Immunohistochemistry was performed to detect the localization of MSH2 in histologically confirmed TERT-mutant and wild-type GBM tissues as described previously (Dixit et al. 2012 
Quantitative reverse transcriptase-PCR (qRT-PCR) analysis
Quantitative RT-PCR analysis for EZH2, FASN, and PGC-1a expressions was performed in TERT-mutant and wild-type GBM samples that were described previously (Ahmad et al. 2016) . Briefly, RNA was isolated and cDNA was synthesized using highcapacity cDNA Reverse Transcription kit (Cat # 43-688-14; Applied Biosystems, Inc., Waltham, MA, USA), and real-time PCR was performed in ViiA7 Real Time Thermocycler (Applied Biosystems) for 40 cycles using Power SYBR Green PCR master mix (Cat # 4367659; Applied Biosystems). The primers used for qRT-PCR are as follows:
MSI analysis
For microsatellite instability (MSI) analysis, multiplex PCR with five quasi-monomorphic mononucleotide repeat markers (BAT25, BAT26, NR21, NR24, and NR27) was performed as described earlier (Goel et al. 2010) . Genomic DNA was isolated from formalin-fixed, paraffin-embedded tumor samples with a QIAamp DNA mini kit (Qiagen, Valencia, CA, USA). Each anti-sense primer was end labeled with one of the fluorescent markers FAM, HEX, or NED. Amplified PCR products were run on an ABI Prism 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Allelic sizes were determined by Gene-mapper 4.1 (Applied Biosystems). Samples with allelic size variations in fewer than two of the microsatellites were classified as microsatellite stable, while samples with allelic size variations in two or more of the microsatellite markers were considered MSI. The primers used for MSI analysis are listed as follows:
BAT 26
Sense 5 Quantitation of free fatty acid Fatty acid level was measured in control, transfected/treated cells, and in xenograft tumor tissues using a fatty acid quantitation kit (Cat # K612; Bio-Vision Inc., Milpitas, CA, USA) according to the manufacturer's instructions.
TUNEL assay
Terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay was performed on glioma cells (10 4 ) treated with betulin as described previously (Ahmad et al. 2016) using In situ Cell Death Detection Kit, TMR red (Cat # 12 156 792 910; Roche Molecular Biochemicals, Indianapolis, IN, USA, SigmaAldrich). Cell death was determined from the ratio of number of TUNEL-positive cells (red) that co-localized with 4 0 ,6-diamidino-2-phenylindole (DAPI; blue) to the total number of cells taken from multiple fields.
Statistical analysis
In in vitro experiments, comparisons between groups were performed using paired Student's t-test. In in vivo experiments, statistical analysis was done using unpaired Student's t-test.
TERT-mutant or wild-type patient samples were analyzed using Mann-Whitney test. All ps < 0.05 were considered significant.
Results

TERT regulates FASN expression and fatty acid accumulation
The ability of SREBP to induce FASN increases the formation of fatty acid and lipid droplets in prostate cancer cells (Huang et al. 2012) . Our recent studies have indicated that TERT inhibition diminishes flux into PPP in glioma cells (Ahmad et al. 2016) . As PPP activation provides substrate for RNA synthesis and co-factors for de novo lipogenesis (Summermatter et al. 2010) , the effect of TERT inhibition on lipid metabolism was investigated. Pharmacological inhibition of TERT by costunolide decreased FASN and SREBP-1 levels ( Fig. 1a and Figure S1a) . A similar decrease was observed upon siRNA-mediated hTERT inhibition ( Fig. 1a and Figure S1a ), or transfection with DN-hTERT ( Fig. 1a and Figure S1a ). Also, both pharmacological and genetic inhibition of TERT decreased fatty acid accumulation (Fig. 1b) .
TERT inhibition represses PGC-1a
Peroxisome proliferator-activated receptor gamma co-activator 1-alpha (PGC-1a) enhances lipogenesis by increasing FASN (Summermatter et al. 2010) . Decrease in PGC-1a expression was observed in costunolide-treated cells exhibiting decreased FASN levels ( Fig. 2a and Figure S2a ). Similar decrease was noted in cells transfected with hTERT siRNA or DN-hTERT ( Fig. 2a and Figure S2a ). Ectopic PGC-1a expression rescues costunolide-mediated decrease in FASN PGC-1a disruption-mediated telomere dysfunction is attributed to TERT down-regulation (Xiong et al. 2015) . Diminished FASN expression in costunolide-treated cells is PGC-1a dependent, as ectopic expression of PGC-1a not only rescued costunolide-induced decrease in FASN and SREBP-1 levels ( Fig. 2b and Figure S2b ), but also prevented costunolide-mediated decrease in fatty acid levels to a significant extent (Fig. 2c) . As FASN inhibition triggers tumor cell apoptosis (Flavin et al. 2010) , the ability of FASN inhibitor betulin to affect glioma cell viability was investigated. Betulin not only induced glioma cell apoptosis ( Figure S3a and b) , but also abrogated TERT levels ( Figure S3c ). These results highlight the functional importance of FASN in glioma cell survival.
Elevated EZH2 expression in TERT promoter mutants Our recent ChIP-seq analysis identified distinct H3K27me3 modification patterns across different grades of astrocytic tumors, without distinguishing between tumors bearing different molecular alterations . Further analysis of the Chip-seq data set for three TERT-mutant and three wild-type tumors indicated showing similar results. Blots were stripped and re-probed for b-actin or c23 to establish equivalent loading. (c) Ectopic expression of PGC-1a rescues costunolide-mediated decrease in fatty acid levels in glioma cells. Graph represents the change in fatty acid levels in cells transfected with mock or PGC-1a over-expression construct in the presence and absence of costunolide. Values represent the means AE SEM of three independent experiments (n = 3). * denotes significant change from mock transfected groups and # depicts significant change from costunolide-treated cells (p < 0.05). Values represent the means AE SEM of three independent experiments (n = 3). * denotes significant change from control (p < 0.05).
lipid metabolism and genomic stability as H3K27me3 targets in GBM bearing hTERT promoter mutations ( Figure S4 ). The targets falling in the protein coding regions were identified and checked for their expression using level 3 The Cancer Genome Atlas expression data of GBM from The Cancer Genome Atlas data portal (http://cancergenome. nih.gov/). Since H3K27me3 modification is involved in mediating gene silencing, we specifically analyzed H3K27me3 targets that had significantly down-regulated levels (Table S1 ).
Existence of EZH2-TERT axis EZH2 promotes glioblastoma tumorigenesis and malignant progression through activation of Warburg effect (Pang et al. 2016) . To understand the correlation between EZH2 and TERT, expression of EZH2 in tumors bearing TERT promoter mutation was investigated. Elevated EZH2 level was observed in TERT promoter mutant GBM tumors as compared to TERT wild-type tumors (Fig. 3a) . A decrease in EZH2 expression was observed upon siRNA-mediated hTERT inhibition ( Fig. 3b and Figure S5a ) and in cells transfected with DN-hTERT ( Fig. 3b and Figure S5a ). This was accompanied by decrease in H3K27me3 levels ( Fig. 3b and Figure S5a ). Conversely, diminished TERT and H3K27me3 expression was observed upon siRNA-mediated EZH2 inhibition ( Fig. 3c and Figure S5b ). This indicates the importance of TERT-EZH2 crosstalk in sustaining heightened levels of both in TERT mutants.
EZH2 regulates lipid metabolism
Analysis of our ChIP-seq data for cases harboring TERT wild-type and mutant indicated PGC-1a to be an EZH2 target in TERT mutants. Since a positive correlation exists between EZH2 and TERT, and as the latter regulates FASN, the involvement of EZH2 in lipid metabolism was investigated. The decrease in FASN and SREBP-1 (Fig. 3d and Figure S5c ) as well as PGC-1a levels ( Fig. 3e and Figure S5d ) observed upon siRNA-mediated EZH2 knockdown was accompanied by diminished fatty acid levels (Fig. 3f) .
TERT-EZH2-ATM crosstalk regulates FASN
Lack of telomere protection triggers DNA damage response (DDR) involving phosphorylation of ATM (Blasco 2005) , and FASN knockdown diminishes DNA damage (Xiao et al. 2008) . Besides its involvement in DDR, ATM activates the PPP to promote anti-oxidant defense (Cosentino et al. 2011) . Importantly, ATM-mediated EZH2 phosphorylation prevents polycomb repressive complex 2 formation and H3K27 methylation (Li et al. 2013) . As TERT inhibition diminishes FASN, the status of ATM under such conditions was investigated. An increase in pATM levels was observed in costunolide-treated cells ( Fig. 4a and Figure S6a ). Similar dependence of ATM phosphorylation on hTERT was also evident from elevated pATM levels in cells transfected with TERT siRNA or DN-hTERT ( Fig. 4a and Figure S6a ). As EZH2 is an ATM target (Li et al. 2013) , the involvement of the latter in EZH2 regulation was investigated. Treatment with ATM kinase inhibitor (KU60019) prevented costunolide-induced decrease in EZH2 (Fig. 4b and Figure S6b ). This increase in ATM phosphorylation is crucial for lipid metabolism, as ATM kinase inhibitor prevented costunolidemediated changes in FASN, SREBP-1 and PGC-1a ( Fig. 4b and Figure S6b ). KU60019 also rescued costunolidemediated decrease in fatty acid accumulation (Fig. 4c) . Besides, elevation in pATM level was observed upon EZH2 inhibition ( Fig. 4d and Figure S6c ). The ability of ATM to negatively regulate lipid metabolism upon TERT inhibition indicates the importance of EZH2-TERT driven DNA damage responses in lipid metabolism.
Correlation between DNA mismatch repair response, ATM, and TERT Mismatch repair response (MMR) pathway affects telomere function as deficiency of MMR gene MSH2 abolishes the anticancer activity of short telomeres (Martinez et al. 2009 ). High telomere mutation frequency is observed in sporadic colon cancers with MSI and lacking MMR gene MSH2 (Pickett et al. 2004) . Changes in MSH2 levels strongly predict the response of GBM tumors to temozolomide treatment (McFaline-Figueroa et al. 2015) . Besides, MSH2 expression can be reversed by simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor with cholesterol-lowering ability (Floer et al. 2008 ). The decrease in MSH2 level observed upon pharmacological inhibition of TERT was reverted in the presence of KU60019 (Fig. 4e and Figure S6d ). EZH2 regulates MSH2 through H3K27me3 (Yang et al. 2016) , and a decrease in MSH2 level was observed upon siRNA-mediated EZH2 knockdown ( Fig. 4f and Figure S6e ).
Elevated FASN and PGC-1a in GBM harboring TERT promoter mutations As our findings indicate a positive correlation between TERT and fatty acid metabolism in glioma cells, the status of FASN in tumors harboring TERT mutations was evaluated. Increased FASN mRNA level was accompanied by elevated PGC-1a expression in TERT mutants ( Fig. 5a and b) . Heightened accumulation of lipid droplets and increased MSH2 expression were observed in TERT mutants as compared to wild-type ( Figure S7a and b) .
Microsatellite instability in TERT mutants MSI pathway involves a failure of the mismatch repair system, and deficiency of MMR enables cells to overcome crises resulting from critical shortening of telomeres (Bechter et al. 2004) . Activation of telomerase is frequent in tumors exhibiting MSI (Ibanez de Caceres et al. 2004) , and FASN over-expression in colorectal cancer is associated with MSI (Ogino et al. 2007 ). Besides, ChIP-seq analysis revealed chromosomal partitioning as an H3K27me3 target in TERT mutants . Although MSI and chromosomal instability have been regarded as mutually exclusive, recent evidence suggests overlap between the two (Trautmann et al. 2006) . As inactivation of any of the several MMR genes, including MSH2 can result in MSI, we investigated MSI in TERT mutants. We tested a panel of five quasi-monomorphic mononucleotide repeat markers amplified in a single multiplex PCR reaction (pentaplex PCR) to detect MSI. The marker panel consisted of BAT25, BAT26, NR21, NR24, and NR27 markers (Goel et al. 2010) . Out of patient tumor samples examined, 30% of the TERT mutants were found to be MSI positive, while only 10% of wild types were MSI positive ( Fig. 5c and Table S2 ). Microsatellite status investigated by PCR with three out of five microsatellite markers analyzed showing evidence of instability suggests that TERT mutant tumors are indeed MSI-high ( Fig. 5c and Figure S8a,b) .
Costunolide affects lipid metabolism in glioma xenograft tumors Costunolide impairs tumor growth, decreases PPP flux and diminishes TERT expression in treated glioma xenograft (Ahmad et al. 2016) . On investigating the effect of costunolide on lipid metabolism in xenograft model, decrease in FASN, SREBP-1, and PGC-1a expression ( Fig. 6a and Figure S9a ), diminished fatty acid levels (Fig. 6b) , and lipid droplet accumulation (Fig. 6c) were observed. Costunolidemediated decrease in EZH2, H3K27me3, and MSH2 levels ( Fig. 6d and Figure S9b ) were accompanied by increased pATM levels ( Fig. 6e and Figure S9c ).
Discussion
Telomere dysfunction represses PGC-1a responses and affects mitochondrial biology (Sahin et al. 2011) . Importantly, PGC-1a plays a pivotal role in progression and metastasis of prostate cancer by modulating the metabolic state of cells (Wallace and Metallo 2016) . The dependence of FASN on PGC-1a is known (Summermatter et al. 2010) , and FASN expression is up-regulated in gliomas (Wakamiya et al. 2014) . Our findings indicate the dependence of PGC-1a and FASN on telomerase activation in glioma cells. Increased fatty acid synthesis promotes tumorigenesis and drug resistance by negatively regulating the DDR pathway (Zeng et al. 2008) . The ability of TERT to drive DNA damage responses and lipogenic flux suggests the existence of an important link between DDR and lipid metabolism in glioblastoma. Thus, in addition to performing its known function of counteracting telomere shortening, hTERT also performs a non-canonical function of regulating lipid metabolism and genomic stability in glioma cells. Regulation of lipogenic genes such as FASN by modulating the association of the repressive H3K27me3 histone marks on their promoters is known (Podrini et al. 2015) . The chromatin state of wild-type and mutant TERT promoters exhibit different marks of active and silenced chromatin (Stern et al. 2015) . Also, our recent genome-wide analysis has revealed a higher enrichment of H3K27me3 targets in glioma stem cells of high-grade GBM as compared to lowgrade tumors , and inhibition of EZH2 activity decreases the glioma stem cell tumorigenicity (Natsume et al. 2013) . Moreover, telomere-shorteninginduced altered H3K27me3 enrichment at Nanog promoter affects the ability to repress pluripotency factors critical to stable differentiation of embryonic stem cells (Pucci et al. 2013) . Elevated EZH2 levels in TERT mutants play a fundamental role in gliomagenesis through epigenetic reprogramming of H3K27me3 modification marks, as EZH2 knockdown not only affected TERT expression but also lipid metabolism. This study has revealed the unanticipated but distinct role of the well-known repressive H3K27me3 mark in regulating lipid metabolism in GBMs harboring distinct molecular alterations. The mechanistic differences between TERT wild types and mutants in terms of this metabolic profile may provide the basis of a rational therapeutic approach.
Depletion of EZH2 decreases the efficiency of DNA double-strand break repair and increases sensitivity of cells to gamma irradiation (Campbell et al. 2013) . EZH2 overexpression confers Cisplatin resistance in ovarian cancer (Hu et al. 2010) . Moreover, deficiency of MMR not only enables the cells to overcome crises resulting from critical shortening of telomeres (Bechter et al. 2004) , but telomerase activation is also frequent in tumors exhibiting MSI (Ibanez de Caceres et al. 2004) resulting from a failure of the MMR system. As FASN over-expression has been associated with MSI in colorectal cancer (Ogino et al. 2007) , the altered status of MSH2 in TERT mutants could account for heightened MSI in these mutants with dysregulated lipid metabolism. Interestingly, telomere instability occurs in MSI-high tumors and is more common than in microsatellite stable cancers (Pickett et al. 2004) . Based on our findings, it seems likely that responsiveness to therapeutic interventions targeting EZH2-TERT-lipid metabolism association in GBM may yield differential responses depending on the status of both TERT promoter mutations and MSI.
This study provides better understanding of aberrant metabolic programming in GBM based on distinctive genetic alterations. From a translational point of view, comprehensive characterization of GBM tumors based on their molecular properties such as genetic alterations, lipid accumulation, microsatellite instability, and histone marks might redefine therapeutic regimens for GBM. Therapeutic strategies aimed at disrupting EZH2-TERT-lipid metabolism interplay are likely to exhibit inherent specificity for TERT mutant as compared to TERT wild-type GBM tumors. All experiments were conducted in compliance with the ARRIVE guidelines.
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